Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.
Staphylococcus aureus superantigens (SAgs) are highly potent T cell mitogens. Antibodies against non-enterotoxin gene cluster (non-egc) SAgs are common in healthy adults, whereas neutralizing antibodies against egc SAgs are rare. We investigated the infecting S. aureus strains and the anti-SAg antibody response during S. aureus bacteremia (SAB). This prospective clinical study (www.clinicaltrials.gov, NCT00548002) included 43 injection drug users (IDUs) and 44 group-matched nonaddicts with SAB. spa genotypes and SAg gene patterns (multiplex PCR) of the S. aureus isolates were determined. The neutralizing capacities of sera obtained at the acute phase and the convalescent phase of SAB were tested against the SAg cocktail of the respective infecting strain and a panel of recombinant SAgs. The lineages CC59 and CC30 were more prevalent among bacteremia strains from IDUs than among strains from nonaddicts. SAg gene patterns in isolates from IDUs and nonaddicts were similar. At the acute phase of bacteremia, IDUs had more neutralizing antibodies against non-egc SAgs than did nonaddicts. Antibody titers frequently increased during infection. In contrast, there were no neutralizing antibodies against egc SAgs at disease onset and such antibodies were not induced by SAB. SAB triggers an antibody response only against non-egc SAgs. Preimmunization in IDU patients is probably due to previous exposure to the infecting strain.
Institute of Immunology and Transfusion Medicine, University of Greifswald, Interimsgebaeude Q05b, Sauerbruchstrasse, D-17487 Greifswald, Germany. dodo.grumann@freenet.de
Dorothee
D
Grumann
Eeva
E
Ruotsalainen
Julia
J
Kolata
Pentti
P
Kuusela
Asko
A
Järvinen
Vesa P
VP
Kontinen
Barbara M
BM
Bröker
Silva
S
Holtfreter
D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000097:blood*; D057134:Antibodies, Neutralizing / Q000097:blood*; D000942:Antigens, Bacterial / Q000235:genetics / Q000276:immunology; D016470:Bacteremia / Q000276:immunology* / Q000382:microbiology; D015373:Bacterial Typing Techniques; D055030:Drug Users; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D058889:Molecular Typing; D011446:Prospective Studies; D013203:Staphylococcal Infections / Q000276:immunology* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000145:classification* / Q000302:isolation & purification; D015819:Substance Abuse, Intravenous / Q000150:complications; D018089:Superantigens / Q000235:genetics / Q000276:immunology*
D000907:Antibodies, Bacterial; D057134:Antibodies, Neutralizing; D000942:Antigens, Bacterial; D018089:Superantigens
J Clin Microbiol. 2003 Dec;41(12):5442-8
14662923
Vaccine. 1998 Nov;16(19):1857-64
9795392
J Infect Dis. 2004 Jun 15;189(12):2334-6
15181583
Mol Nutr Food Res. 2004 Dec;48(7):488-95
15515095
J Clin Microbiol. 2006 Jul;44(7):2533-40
16825376
J Infect Dis. 2009 Mar 1;199(5):625-32
19199541
Lancet Infect Dis. 2005 Dec;5(12):751-62
16310147
J Intern Med. 2006 Feb;259(2):179-90
16420547
Infect Immun. 1998 Jul;66(7):3337-48
9632603
J Appl Microbiol. 2003;95(1):38-43
12807452
Infect Immun. 2004 Jul;72(7):4061-71
15213151
Scand J Infect Dis. 1985;17(2):179-87
4023635
J Clin Microbiol. 2010 May;48(5):1527-35
20200289
J Infect Dis. 1974 Jul;130(1):1-7
4209863
J Infect Dis. 2007 Sep 1;196(5):738-47
17674317
J Bacteriol. 2005 Aug;187(16):5585-94
16077103
J Infect. 2008 Apr;56(4):249-56
18314197
Annu Rev Microbiol. 2001;55:77-104
11544350
J Infect Dis. 2009 Jun 15;199(12):1820-6
19419332
Infection. 2004 Jun;32(3):163-9
15188077
Infect Immun. 2002 Feb;70(2):631-41
11796592
FEMS Microbiol Lett. 2005 Feb 15;243(2):447-54
15686848
J Med Microbiol. 2004 Mar;53(Pt 3):223-227
14970247
Infect Immun. 2002 Sep;70(9):4987-96
12183545
Funct Integr Genomics. 2006 Jul;6(3):186-201
16453141
Clin Microbiol Infect. 2009 Feb;15(2):137-43
19178545
Chem Immunol Allergy. 2007;93:24-41
17369698
J Clin Microbiol. 2006 Feb;44(2):619-21
16455927
Lancet Infect Dis. 2002 Oct;2(10):605-12
12383610
J Clin Microbiol. 2007 Aug;45(8):2669-80
17537946
J Infect Dis. 1996 Aug;174(2):338-45
8699064
Infect Immun. 2002 May;70(5):2278-81
11953360
Medicine (Baltimore). 1983 May;62(3):170-7
6843356
J Infect Dis. 1974 Jun;129(6):725-7
4834284
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;270(1-2):110-4
3223132
J Immunol. 2008 Oct 1;181(7):5054-61
18802109
Zentralbl Bakteriol. 1989 Oct;271(4):486-92
2818798
J Infect Dis. 1999 Oct;180(4):1370-3
10479175
Arch Immunol Ther Exp (Warsz). 2005 Jan-Feb;53(1):13-27
15761373
Eur J Clin Microbiol Infect Dis. 2009 Sep;28(9):1159-65
19434432
J Clin Invest. 1993 Feb;91(2):602-7
8432865
Clin Exp Immunol. 2003 Sep;133(3):299-306
12930353
J Immunol. 2001 Jan 1;166(1):669-77
11123352
J Med Microbiol. 1996 Mar;44(3):171-7
8636933
J Infect Dis. 2006 May 1;193(9):1275-8
16586365
Infect Immun. 2008 Nov;76(11):4999-5005
18710864
JAMA. 2005 Jun 22;293(24):3012-21
15972563
Ann Intern Med. 1975 Jun;82(6):788-90
1138588